Bruce retired from Mintz in 2026. He was Chair of the firm's Antitrust Practice.
Experience
viewpoints
FTC Flushes McWane in a Big Eleventh Circuit Exclusive Dealing Win
April 22, 2015 | Alert | By Bruce Sokler, Helen Kim, Timothy Slattery
The situations where exclusive dealing policies, explicit or tied to an aggressive discounting program, cross the line under the rule-of-reason remain far from clear.
Read more
FTC Settles Radioactive Allegations Against Cardinal Health with a Near Record-Breaking Disgorgement Agreement
April 21, 2015 | Alert | By Bruce Sokler, Dionne Lomax, Helen Kim
In a 3-2 decision, as part of its aggressive antitrust enforcement in health care industries, the Federal Trade Commission (FTC or the Commission) announced that Cardinal Health, Inc. (Cardinal) agreed to pay $26.8 million to resolve the FTC’s allegations that Cardinal illegally monopolized the sale of low-energy radiopharmaceutical drugs in 25 geographic markets and inflated prices charged to hospitals and clinics for the drugs.
Read more
You're Invited to a Webinar: Health Care Antitrust Trends in 2015
April 17, 2015 | Blog | By Samantha Kingsbury
Next Thursday April 23rd at 12pm EST, Mintz Levin attorneys Dionne Lomax and Steve Weiner will be presenting a webinar, moderated by Bruce Sokler, on trends in antitrust enforcement in health care.
Read more
Hospital Wins First Round Against Largest Rival in Antitrust Suit Alleging Illegal Exclusive Dealing Agreements with Insurers
March 30, 2015 | Alert | By Bruce Sokler, Dionne Lomax, Robert Kidwell, Farrah Short
The waves of change affecting health care providers include reimbursement and funding developments, the impact of the Affordable Care Act, technological and medical advances, provider network design transformations imposed by payors — and antitrust.
Read more
FTC Looks to Accelerate Oncology Drug Growth by Requiring Novartis to Divest Two Protein Inhibitors in Its Clinical Development Pipeline
February 27, 2015 | Alert | By Bruce Sokler, Timothy Slattery
The Federal Trade Commission (“FTC”) on Monday completed its review of Novartis AG’s (“Novartis”) proposed $16 billion acquisition of GlaxoSmithKline’s (“GSK”) oncology drug portfolio with an announced consent decree that requires limited divestitures of BRAF- and MEK-inhibitor drugs used to treat melanoma, ovarian, colorectal, non-small cell lung, and other cancers.
Read more
Supreme Court Rejects Antitrust Immunity for North Carolina Dental Board
February 27, 2015 | Blog | By Theresa Carnegie
On February 25, 2015, in a 6-3 decision authored by Justice Kennedy, the Supreme Court upheld the Federal Trade Commission’s decision finding that the North Carolina Board of Dental Examiners, although a state agency, was not exempt from federal antitrust laws when it sent 47 official cease-and-desist letters to non-dentist teeth whitening service providers.
Read more
No Active State Supervision, No Antitrust Immunity for North Carolina State Dental Board
February 26, 2015 | Alert | By Bruce Sokler, Helen Kim
On February 25, 2015, in a 6-3 decision authored by Justice Kennedy, the Supreme Court upheld the Federal Trade Commission’s (FTC) decision finding that the North Carolina Board of Dental Examiners (Board), although a state agency, was not exempt from federal antitrust laws when it sent 47 official cease-and-desist letters to non-dentist teeth whitening service providers.
Read more
Ninth Circuit Affirms FTC’s Challenge to Hospital-Physician Group Merger, While Rejecting Efficiencies and Health Care Quality Arguments
February 11, 2015 | Alert | By Bruce Sokler, Dionne Lomax, Robert Kidwell, Farrah Short
In a much anticipated appellate health care antitrust decision, the United States Court of Appeals for the Ninth Circuit upheld a district court’s finding that a consummated hospital-physician group merger violated Section 7 of the Clayton Act, despite the provider-defendants’ assertion of an efficiencies defense based on integrated care and risk-based reimbursement.
Read more
DOJ Releases Electrifying New Guidance on Standard-Essential Patent Policy
February 10, 2015 | Alert | By Bruce Sokler, Timothy Slattery
The Department of Justice (the “Department” or “DOJ”) continued its multi-pronged defense of standards-setting organizations (SSOs) who adopt patent policies to prevent hold-up during licensing negotiations.
Read more
FTC and DOJ to Host Second Public Workshop on Health Care Competition
January 26, 2015 | Alert | By Bruce Sokler, Farrah Short
Last March, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) began a public workshop series entitled, “Examining Health Care Competition.”
Read more
News & Press
Five Mintz Attorneys Recognized as ‘Top Authors’ by JD Supra
February 24, 2026|
How DOJ's Visa Debit Monopolization Suit May Unfold
October 28, 2024|
FTC Theories Of Harm After Anesthesia Co. Ruling
June 3, 2024|
The Capitol Forum Interviews Mintz's Bruce Sokler
April 22, 2024|
Are the Google, Amazon Suits This Generation's Microsoft?
November 26, 2023|
Thirteen Mintz Members Named To Lawdragon 500 Leading Litigators List
September 11, 2023|
FTC Pharma Merger Digest May Offer Policy Clues
June 15, 2023|
FTC Shift In Compulsory Process Lends Staff More Clout
September 12, 2022|
Poultry Sector Wage-Fixing Case Shows Info Exchange Risks
August 31, 2022|
Private Equity On Notice Due To Vet Clinic FTC Settlement
June 16, 2022|
Five Mintz Attorneys Recognized as Client Service All-Stars by BTI
February 8, 2022|
Biden Enforcers Fail to Stem Rising Merger Tide
October 22, 2021|
Mintz Attorneys and Practices Recognized by Chambers USA 2020
April 24, 2020|
One Hundred Mintz Attorneys Ranked as Leaders by Best Lawyers 2020
August 15, 2019|
Mintz Recognized by Chambers USA 2019
April 26, 2019|
Antitrust Case against BCBS to Continue under Per Se Standard
February 1, 2019|
Chambers USA 2018 Ranks Mintz Attorneys & Practices
May 3, 2018|
Mintz Honored by JD Supra's 2018 Reader's Choice Awards
March 19, 2018|
Antitrust World Eyes Justices On AmEx Steering Case
February 23, 2018|
Hospital Consolidation
December 4, 2017|
What’s at Stake in the AmEx Merchant Rules Case?
October 16, 2017|
Physician Practice Acquisitions And Antitrust Scrutiny
September 19, 2017|
DOJ About-Face In High Court AmEx Case Has Attys Puzzled
August 9, 2017|
Chambers USA 2017 Ranks Mintz Attorneys & Practices
May 26, 2017|
Discord Between Ballad Health and the FTC
April 23, 2017|
Emboldened, the FTC Seems Ready to Fight More Mergers
November 21, 2016|
Chicago Hospital Case Could Hinge on Efficiency Argument
November 3, 2016|
Mintz Represents Seventh Generation, Inc. in Sale to Unilever
October 27, 2016|
FTC wins appeal to halt Penn State Hershey/PinnacleHealth merger
September 28, 2016|
Hospital Merger Stalls After FTC Court Win
September 27, 2016|
DOJ Loss In AmEx Case Could Imperil Hospital Steering Suit
September 27, 2016|
Six Mintz Members to Speak at 2016 IBA Annual Conference
September 12, 2016|
What Have Merchants Gained From Payment Card Litigation?
August 10, 2016|
5 Questions To Watch As DOJ Targets Carolinas HealthCare
June 13, 2016|
49 Mintz Attorneys Featured in Chambers USA 2016 Guide
May 31, 2016|
5 Ways to Ease the Pain of an Antitrust Review
May 23, 2016|
Rodeo Associations Fail to Rein in Each Other in Round 1
February 9, 2016|
Mintz’s Wins Significant Antitrust Case for C-SPAN
June 10, 2013|
Mintz Advises on Top Greentech Deal of 2012
January 8, 2013|
podcasts
Biden’s Executive Order on Antitrust Competition: What Does It Mean for the Health Care Industry?
July 19, 2021 | Podcast | By Bruce Sokler
Joe Miller and Bruce Sokler, Co-Chairs of Mintz's Antitrust Practice, discuss President Biden’s July 9 executive order, which called for a government-wide focus on antitrust competition issues and identified 72 initiatives across several industries.
Read more
Events & Speaking
Panelist
Speaker
Speaker
Speaker
May
17
2018
Antitrust in Healthcare
American Bar Association and American Health Lawyers Association
The Ritz-Carlton Arlington, VA
Speaker
Speaker
Speaker
Moderator
Read less
Apr
23
2015
Recent Insights
